Silexion flags going-concern doubt as cash dwindles to $2.4M amid 44% jump in burn rate

Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read

Key Changes

• high

  Management disclosed substantial doubt about continuing as a going concern, stating current cash will fund operations for only several months. Cash fell 61% year-over-year to $2.4M while quarterly burn jumped 44% to $3.6M.

  MD&A: Liquidity verify on EDGAR →
• high

  Q1 2026 net loss rose 57% to $2.7M from $1.7M prior year, driven by increased R&D spending on GMP manufacturing and clinical trial prep. Company raised only $0.08M through ATM sales in Q1, with subsequent April-May sales at declining prices ($1.14 to $0.32 per share).

  MD&A: Results of Operations verify on EDGAR →
• high

  Former sponsor disputes conversion of $1.2M note into shares and demands cash repayment. Company asserts conversion was valid but faces potential cash claim amid acute liquidity pressure.

  MD&A: Sponsor Note verify on EDGAR →